The Company is a Korea-based company formed for the sole purpose of merging with existing corporations. The Company focuses its merger targets in: new regeneration energy industry, biomedicines and bio medical equipment industry, information technology (IT) convergence systems industry, light emitting diode (LED) applications industry, green transportation systems industry, carbon reduction technologies industry, advanced water treatments industry, advanced green city plans industry, convergence of broadcastings and telecommunications industry, robot applications industry, the convergence of advanced materials and nanotechnologies industry, high value-added food industry, entertainment industry, vehicle parts manufacture industry, IT industry and semiconductor industry. The Company was established on November 03, 2017. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on June 08 2018.
Headquarters
82, Uisadang-Daero, Yeongdeungpo-Gu
Seoul; Seoul;
Contact Details: Purchase the Kainos Medicine, Inc. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service